Search research articles
Contact Us
Filters
Showing results (131-140 of 142) with videos related to
Page
of 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2014
FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation
Geoffrey Kim, Amy E McKee, Yang-Min Ning, et al.
Journal of Advanced Nursing
|
April 25, 2022
Nurses' strategies for overcoming barriers to fundamental nursing care in patients with COVID-19 caused by infection with the SARS-COV-2 virus: Results from the 'COVID-NURSE' survey
Holly V R Sugg, David A Richards, Anne-Marie Russell, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 20, 2021
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement
Kerri I Aronson, Sonye K Danoff, Anne-Marie Russell, et al.
JAMA
|
April 10, 2008
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial
Barbara V Howard, Mary J Roman, Richard B Devereux, et al.
Rheumatology (Oxford, England)
|
July 14, 2023
Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis
Lesley Ann Saketkoo, Antonia Valenzuela, Susan Kim, et al.
Journal of Advanced Nursing
|
November 21, 2023
Evaluation of a COVID-19 fundamental nursing care guideline versus usual care: The COVID-NURSE cluster randomized controlled trial
David A Richards, Jess Bollen, Ben Jones, et al.
Frontiers in Pharmacology
|
October 31, 2022
World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease
Lesley Ann Saketkoo, Reuben Escorpizo, Janos Varga, et al.
BMJ Open
|
May 27, 2021
COVID-NURSE: evaluation of a fundamental nursing care protocol compared with care as usual on experience of care for noninvasively ventilated patients in hospital with the SARS-CoV-2 virus-protocol for a cluster randomised controlled trial
David A Richards, Holly Vr Sugg, Emma Cockcroft, et al.
BMJ Open
|
November 16, 2021
Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outcomes measures for clinical use in patients with COVID-19: a report of the International Consortium for Health Outcomes Measurement (ICHOM) COVID-19 Working Group
William H Seligman, Luz Fialho, Nick Sillett, et al.
The Lancet. Respiratory Medicine
|
September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
Dina Visca, Letizia Mori, Vicky Tsipouri, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 142) with videos related to
Sort By:
Page
of 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2014
FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation
Geoffrey Kim, Amy E McKee, Yang-Min Ning, et al.
Journal of Advanced Nursing
|
April 25, 2022
Nurses' strategies for overcoming barriers to fundamental nursing care in patients with COVID-19 caused by infection with the SARS-COV-2 virus: Results from the 'COVID-NURSE' survey
Holly V R Sugg, David A Richards, Anne-Marie Russell, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 20, 2021
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement
Kerri I Aronson, Sonye K Danoff, Anne-Marie Russell, et al.
JAMA
|
April 10, 2008
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial
Barbara V Howard, Mary J Roman, Richard B Devereux, et al.
Rheumatology (Oxford, England)
|
July 14, 2023
Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis
Lesley Ann Saketkoo, Antonia Valenzuela, Susan Kim, et al.
Journal of Advanced Nursing
|
November 21, 2023
Evaluation of a COVID-19 fundamental nursing care guideline versus usual care: The COVID-NURSE cluster randomized controlled trial
David A Richards, Jess Bollen, Ben Jones, et al.
Frontiers in Pharmacology
|
October 31, 2022
World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease
Lesley Ann Saketkoo, Reuben Escorpizo, Janos Varga, et al.
BMJ Open
|
May 27, 2021
COVID-NURSE: evaluation of a fundamental nursing care protocol compared with care as usual on experience of care for noninvasively ventilated patients in hospital with the SARS-CoV-2 virus-protocol for a cluster randomised controlled trial
David A Richards, Holly Vr Sugg, Emma Cockcroft, et al.
BMJ Open
|
November 16, 2021
Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outcomes measures for clinical use in patients with COVID-19: a report of the International Consortium for Health Outcomes Measurement (ICHOM) COVID-19 Working Group
William H Seligman, Luz Fialho, Nick Sillett, et al.
The Lancet. Respiratory Medicine
|
September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
Dina Visca, Letizia Mori, Vicky Tsipouri, et al.
Page
of 15